Upgrade to SI Premium - Free Trial

Hologic (HOLX): Aesthetics Miss Overshadows Improvement in Other Areas - Needham

November 9, 2017 7:51 AM
Needham & Company analyst, Mike Matson, reiterated his Buy rating on shares of Hologic (NASDAQ: HOLX) but cut his price ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

Categories

Analyst EPS Change Analyst EPS View Analyst PT Change

Next Articles